YungShin Global Holding Corporation Stock

Equities

3705

TW0003705000

Pharmaceuticals

End-of-day quote Taiwan S.E. 18:00:00 2024-05-15 EDT 5-day change 1st Jan Change
53.1 TWD +1.34% Intraday chart for YungShin Global Holding Corporation +5.15% +14.19%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 7.31B 227M 309M Sales 2023 7.03B 219M 297M Capitalization 12.39B 385M 524M
Net income 2022 839M 26.09M 35.48M Net income 2023 827M 25.72M 34.97M EV / Sales 2022 1.65 x
Net cash position 2022 192M 5.98M 8.13M Net cash position 2023 570M 17.73M 24.11M EV / Sales 2023 1.68 x
P/E ratio 2022
14.6 x
P/E ratio 2023
15 x
Employees -
Yield 2022
5%
Yield 2023
4.95%
Free-Float 63.45%
More Fundamentals * Assessed data
Dynamic Chart
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
YungShin Global Holding Corporation Announces Cash Dividend, Payable on July 17, 2024 CI
Yungshin Global Holding Corporation Announces Resignation of Fang-Hsin Lee as Chairperson of Carlsbad Technology, Inc, Effective April 1, 2024 CI
YungShin Global Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
YungShin Global Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
YungShin Global Holding Corporation Announces President Changes CI
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
YungShin Global Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yungshin Global Holding Corporation Announces Cash Dividend, Payable on July 13, 2023 CI
YungShin Global Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Forward BioT Venture Capital announced that it expects to receive TWD 60 million in funding from YungShin Global Holding Corporation CI
YungShin Global Holding Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
YungShin Global Holding Corporation agreed to acquire Yung Shin China Holding Co. Ltd and Yung Shin Pharmaceutical Ind. Co., Ltd. CI
YungShin Global Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+1.34%
1 week+5.15%
Current month+8.70%
1 month+11.20%
3 months+14.69%
6 months+16.96%
Current year+14.19%
More quotes
1 week
50.50
Extreme 50.5
53.20
1 month
47.65
Extreme 47.65
53.20
Current year
45.80
Extreme 45.8
53.20
1 year
42.75
Extreme 42.75
53.20
3 years
37.20
Extreme 37.2
53.20
5 years
36.55
Extreme 36.55
53.20
10 years
36.55
Extreme 36.55
68.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director/Board Member 61 12-06-30
Members of the board TitleAgeSince
Director/Board Member - 13-06-10
Director/Board Member 75 10-06-08
Chief Executive Officer 68 10-06-08
More insiders
Date Price Change Volume
24-05-15 53.1 +1.34% 957 905
24-05-15 52.4 -0.38% 446,891
24-05-14 52.6 -0.38% 922,475
24-05-13 52.8 +2.92% 1,585,984
24-05-10 51.3 +1.38% 989,124

End-of-day quote Taiwan S.E., May 15, 2024

More quotes
YungShin Global Holding Corp is a Taiwan-based company mainly engaged in the manufacture and sale of human pharmaceutical medicine and animal medicine. The Company mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The Company also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW